欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	DK/H/1735/001
药品名称	Meropenem Hospira
活性成分	meropenem trihydrate 500.0 mg
剂型	Powder for solution for injection
上市许可持有人	Hospira UK Limited Queensway, Royal Leamington Spa Warwickshire, CV 31 3RW United Kingdom
参考成员国 - 产品名称	Denmark (DK)
互认成员国 - 产品名称	Germany (DE) France (FR) Sweden (SE) Poland (PL) Luxembourg (LU) Norway (NO) Belgium (BE) Ireland (IE)
许可日期	2010/06/14
最近更新日期	2024/05/28
药物ATC编码	J01DH02 meropenem
申请类型	TypeLevel1：Abridged TypeLevel2：Initial Application TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC TypeLevel4：Chemical Substance TypeLevel5：Prescription Only
附件文件下载	PAR \| parmod5_dk1735meropenemhospira.pdfDate of last change:2022/06/02 Final SPC \| dk-h-1735 common-spc-cleanDate of last change:2017/03/30 Final PL \| dk-h-1735-001-002-ib-025-g common-pil-cleanDate of last change:2017/03/30 Final Labelling \| common-impack-1gDate of last change:2014/09/04 Final Labelling \| common-impack-500mgDate of last change:2014/09/04 Final Labelling \| common-outer-1gDate of last change:2014/09/04 Final Labelling \| common-outer-500mgDate of last change:2014/09/04
市场状态	Positive